A skin cleansing article configured to deliver cosmetics or dermal therapies to a user's skin and a method of making the same are provided. For example, the skin cleansing article includes a core substrate comprising a resin. The core substrate has a first region containing a first active cleansing formulation and a second region containing a second active cleansing formulation. The skin cleansing article is substantially dry or solid and is water-dispersible or water-soluble. When the water-soluble core substrate is contacted with water having a temperature greater than 10° C. for a period of time, the core substrate is dispersible or soluble according to Testing Method MSTM-205 to release the first active cleansing formulation and/or the second active cleansing formulation.

Disclosed are personal care compositions, e.g., skin care compositions, comprising an acyl glutamate, e.g., sodium cocoyl glutamate, in an amount of from 1% to 10% by weight of the composition and at least one topically active compound, wherein the at least one topically active compound comprises a vitamin, as well as to methods of using these compositions.

Disclosed are personal care compositions, e.g., skin care compositions, comprising an acyl glutamate, e.g., sodium cocoyl glutamate, in an amount of from 1% to 10% by weight of the composition and at least one topically active compound, wherein the at least one topically active compound comprises a vitamin, as well as to methods of using these compositions.

A cleansing substrate comprising a formulation selected from the group consisting of distilled water, lemon juice, liquid aloe, aloe gel, liposomal Vitamin C, Zing, B5, B6 Keratin, Grapefruit seed oil, Vitamin E oil, Critic acid, and menthol. Wherein the cleansing substrate is used to clean and treat the hair and scalp of a person.

A cleansing substrate comprising a formulation selected from the group consisting of distilled water, lemon juice, liquid aloe, aloe gel, liposomal Vitamin C, Zing, B5, B6 Keratin, Grapefruit seed oil, Vitamin E oil, Critic acid, and menthol. Wherein the cleansing substrate is used to clean and treat the hair and scalp of a person.

Embodiments of the present disclosure may include a skincare composition comprising an antimicrobial component, an antiaging component and a moisturizing component comprising at least one alpha-hydroxy acid. A treatment method for improving skin may include administering to an area in need thereof a composition comprising an effective amount of an antimicrobial component, an antiaging component and a moisturizing component comprising at least one alpha-hydroxy acid.

Embodiments of the present disclosure may include a skincare composition comprising an antimicrobial component, an antiaging component and a moisturizing component comprising at least one alpha-hydroxy acid. A treatment method for improving skin may include administering to an area in need thereof a composition comprising an effective amount of an antimicrobial component, an antiaging component and a moisturizing component comprising at least one alpha-hydroxy acid.

The antimicrobial composition of the present invention comprises a cationic active ingredient, a foam boosting surfactant, a foam boosting copolymer, a foam stabilizer, and a chelating agent. The present antimicrobial compositions are free of the antimicrobial agent triclosan (i.e., 2,4,4′-trichloro-2′hydroxy-diphenylether), have rapid cidal activity, provide stable copious foam and exhibit enhanced tissue (e.g. skin) compatibility as defined by an in vitro whole toxicology assessment method.

The antimicrobial composition of the present invention comprises a cationic active ingredient, a foam boosting surfactant, a foam boosting copolymer, a foam stabilizer, and a chelating agent. The present antimicrobial compositions are free of the antimicrobial agent triclosan (i.e., 2,4,4′-trichloro-2′hydroxy-diphenylether), have rapid cidal activity, provide stable copious foam and exhibit enhanced tissue (e.g. skin) compatibility as defined by an in vitro whole toxicology assessment method.

The present invention relates to novel selective melanocortin-1 receptor (MC1R) agonists as well as the use thereof as skin tanning agents.